NCT05939466View on ClinicalTrials.gov

Medical Cannabis for Treating Pain Related to Fibromyalgia

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

September 1, 2021

Study Completion Date

September 30, 2021

Conditions
Fibromyalgia
Interventions
DRUG

Bedrocan®-type cannabis (22% THC, <1% CBD)

Decoction with 100 mg of Bedrocan®-type cannabis (22% THC, \<1% CBD)

Trial Locations (1)

85100

Pain Therapy Unit, San Carlo Hospital, Potenza

All Listed Sponsors
collaborator

San Carlo Public Hospital, Potenza, Italy

OTHER

lead

Universita degli Studi della Basilicata

OTHER

NCT05939466 - Medical Cannabis for Treating Pain Related to Fibromyalgia | Biotech Hunter | Biotech Hunter